Cutaneous pigmentation after daunorubicin chemotherapy.
Anderson
L L
LL
Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, TX 78234-6200.
Thomas
D E
DE
Berger
T G
TG
Vukelja
S J
SJ
D000328:Adult; D003630:Daunorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D009260:Nail Diseases / Q000139:chemically induced*; D010859:Pigmentation Disorders / Q000139:chemically induced*
D003630:Daunorubicin